705 related articles for article (PubMed ID: 18050188)
1. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.
Tomietto P; Annese V; D'agostini S; Venturini P; La Torre G; De Vita S; Ferraccioli GF
Arthritis Rheum; 2007 Dec; 57(8):1461-72. PubMed ID: 18050188
[TBL] [Abstract][Full Text] [Related]
2. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
Mikdashi J; Handwerger B
Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
[TBL] [Abstract][Full Text] [Related]
3. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
4. [Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon].
Annese V; Tomietto P; Venturini P; D'Agostini S; Ferraccioli G
Reumatismo; 2006; 58(1):50-8. PubMed ID: 16639488
[TBL] [Abstract][Full Text] [Related]
5. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
McLaurin EY; Holliday SL; Williams P; Brey RL
Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease.
Kozora E; West SG; Kotzin BL; Julian L; Porter S; Bigler E
Arthritis Rheum; 1998 Jan; 41(1):41-7. PubMed ID: 9433868
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment and employment status in systemic lupus erythematosus: a prospective longitudinal study.
Appenzeller S; Cendes F; Costallat LT
Arthritis Rheum; 2009 May; 61(5):680-7. PubMed ID: 19405004
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.
Kozora E; Arciniegas DB; Filley CM; West SG; Brown M; Miller D; Grimm A; Devore MD; Wingrove C; Zhang L
Arthritis Rheum; 2008 Nov; 59(11):1639-46. PubMed ID: 18975359
[TBL] [Abstract][Full Text] [Related]
10. Cognitive dysfunction in systemic lupus erythematosus.
Emori A; Matsushima E; Aihara O; Ohta K; Koike R; Miyasaka N; Kato M
Psychiatry Clin Neurosci; 2005 Oct; 59(5):584-9. PubMed ID: 16194262
[TBL] [Abstract][Full Text] [Related]
11. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
Appenzeller S; Pereira DA; Costallat LT
Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
[TBL] [Abstract][Full Text] [Related]
12. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.
Ainiala H; Dastidar P; Loukkola J; Lehtimäki T; Korpela M; Peltola J; Hietaharju A
Scand J Rheumatol; 2005; 34(5):376-82. PubMed ID: 16234185
[TBL] [Abstract][Full Text] [Related]
13. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.
Harrison MJ; Ravdin LD; Lockshin MD
Arthritis Rheum; 2006 Aug; 54(8):2515-22. PubMed ID: 16868972
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies.
Nery FG; Borba EF; Viana VS; Hatch JP; Soares JC; Bonfá E; Neto FL
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):695-700. PubMed ID: 18077068
[TBL] [Abstract][Full Text] [Related]
15. Cerebral and corpus callosum atrophy in systemic lupus erythematosus.
Appenzeller S; Rondina JM; Li LM; Costallat LT; Cendes F
Arthritis Rheum; 2005 Sep; 52(9):2783-9. PubMed ID: 16142703
[TBL] [Abstract][Full Text] [Related]
16. Predictors of damage progression in Portuguese patients with systemic lupus erythematosus.
Santos MJ; Vinagre F; Nero P; Barcelos F; Barcelos A; Rodrigues AM; de Matos AA; Silva C; Miranda L; Capela S; Marques A; Branco J; da Silva JC
Ann N Y Acad Sci; 2009 Sep; 1173():822-8. PubMed ID: 19758234
[TBL] [Abstract][Full Text] [Related]
17. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus.
Denburg SD; Carbotte RM; Ginsberg JS; Denburg JA
J Int Neuropsychol Soc; 1997 Jul; 3(4):377-86. PubMed ID: 9260447
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage.
Ruperto N; Buratti S; Duarte-Salazar C; Pistorio A; Reiff A; Bernstein B; Maldonado-Velázquez MR; Beristain-Manterola R; Maeno N; Takei S; Falcini F; Lepore L; Spencer CH; Pratsidou-Gertsi P; Martini A; Ravelli A
Arthritis Rheum; 2004 Jun; 51(3):458-64. PubMed ID: 15188334
[TBL] [Abstract][Full Text] [Related]
19. Cognitive function in a systemic lupus erythematosus inception cohort.
Petri M; Naqibuddin M; Carson KA; Sampedro M; Wallace DJ; Weisman MH; Holliday SL; Padilla PA; Brey RL
J Rheumatol; 2008 Sep; 35(9):1776-81. PubMed ID: 18634154
[TBL] [Abstract][Full Text] [Related]
20. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.
Tektonidou MG; Varsou N; Kotoulas G; Antoniou A; Moutsopoulos HM
Arch Intern Med; 2006 Nov; 166(20):2278-84. PubMed ID: 17101948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]